T1	Participants 16 54	advanced gastric carcinoma (stage IV):
T2	Participants 105 181	Forty-six patients with advanced gastric carcinoma (Stage IV) were evaluated
T3	Participants 390 511	Thirty-three patients had measurable disease and thirteen had only microscopic residual disease in the resection margins.
T4	Participants 1296 1313	Thirteen patients
